Aspirin in pregnant patients with essential thrombocythemia: a retrospective analysis of 129 pregnancies

The findings in the current study suggest that aspirin may be effective during the pregnancy of ET patients, especially when the JAK2 (V617F) mutation is present. However, the use of aspirin in pregnancy deserves further investigation in a prospective trial